RightAnswer Knowledge Solutions Search Results for 62-33-9

New Search  |  Search Results (62-33-9)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • MSDS Documents
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp


All Other Data Sources:

CCRIS Documentshelp
CHRIS Documentshelp
DART Documentshelp
ECOTOX Documentshelp
Fisher MSDShelp
GENE-TOX Documentshelp
HSDB® Data Bankhelp
LOLI® Listingshelp
• Calcium disodium ethylenediaminetetraacetate ( 100333-49-1)
• Calcium disodium ethylenediaminetetraacetate ( 108703-54-4)
• Calcium disodium ethylenediaminetetraacetate ( 12002-29-8)
• Calcium disodium ethylenediaminetetraacetate ( 12558-50-8)
• Calcium disodium ethylenediaminetetraacetate ( 1282-71-9)
• Calcium disodium ethylenediaminetetraacetate ( 1288-07-9)
• Calcium disodium ethylenediaminetetraacetate ( 19067-42-6)
• Calcium disodium ethylenediaminetetraacetate ( 35-00-7)
• Calcium disodium ethylenediaminetetraacetate ( 39208-14-5)
• Calcium disodium ethylenediaminetetraacetate ( 50322-17-3)
• Calcium disodium ethylenediaminetetraacetate ( 5297-15-4)
• Calcium disodium ethylenediaminetetraacetate ( 5639-01-0)
• Calcium disodium ethylenediaminetetraacetate ( 56532-88-8)
• Calcium disodium ethylenediaminetetraacetate ( 57131-51-8)
• Calcium disodium ethylenediaminetetraacetate ( 61864-74-2)
• Calcium disodium ethylenediaminetetraacetate ( 63042-69-3)
• Calcium disodium ethylenediaminetetraacetate ( 68162-45-8)
• Calcium disodium ethylenediaminetetraacetate ( 69843-95-4)
• Calcium disodium ethylenediaminetetraacetate ( 74011-06-6)
• Calcium disodium ethylenediaminetetraacetate ( 7732-93-6)
• Disodium calcium EDTA ( 62-33-9)
• Ethylenediaminetetraacetic acid ( 13440-78-3)
• Ethylenediaminetetraacetic acid ( 161122-33-4)
• Ethylenediaminetetraacetic acid ( 20539-27-9)
• Ethylenediaminetetraacetic acid ( 26627-46-3)
• Ethylenediaminetetraacetic acid ( 30485-87-1)
• Ethylenediaminetetraacetic acid ( 30485-88-2)
• Ethylenediaminetetraacetic acid ( 30485-90-6)
• Ethylenediaminetetraacetic acid ( 32757-10-1)
• Ethylenediaminetetraacetic acid ( 402925-67-1)
• Ethylenediaminetetraacetic acid ( 60-00-4)
• Ethylenediaminetetraacetic acid ( 675141-16-9)
• Ethylenediaminetetraacetic acid ( 94108-75-5)
New Jersey Fact Sheetshelp
OHM/TADS Documentshelp
• EDTA
REPROTOX® Documentshelp
• EDTA
RTECS® Registryhelp
Shepard's Cataloghelp
MSDSonline®help

ChemID External Links:


Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for 62-33-9:


Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

  1. WITH THERAPEUTIC USE
    1. The following adverse effects have been reported with the use of edetate calcium disodium: Inverted T waves and cardiac rhythm irregularities, transient decreases in blood pressure, acute necrosis of the proximal tubules, microscopic hematuria, glycosuria, proteinuria, nephrotoxicity, acute renal failure, dermatitis and exfoliative dermatitis of the scrotum, injection site pain following intramuscular injection, hypocalcemia, hypercalcemia, nausea, vomiting, abdominal pain, diarrhea, mild elevations in SGOT and SGPT, anemia, bone marrow depression, fatigue, myalgia, zinc deficiency, headache, tremors, numbness, and tingling.
    1. In patients with lead encephalopathy, edetate calcium disodium may worsen cerebral edema. For patients with lead encephalopathy, edetate calcium disodium should be begun 4 hours after administration of dimercaprol.
  1. WITH POISONING/EXPOSURE
    1. No ill effects were observed following inadvertent administration of 5 times the recommended dose, infused intravenously over a 24-hour period of time, to an asymptomatic 16-month-old with a blood lead level of 56 mcg/dL
© 2011-2017 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.